Davis Polk advised the representatives of the several underwriters in the offering.Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at $17.00…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now